• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 95 of 100
pancreatic cancer cell
TechHow one company is using artificial intelligence to develop a cure for cancer
By Cyrus SanatiApril 16, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
FeaturesAmericans spent a record amount on medicine in 2014
By TIMEApril 14, 2015
IL: Corporations In Illinois
FinanceHospira hit with further FDA scrutiny after $17 billion Pfizer deal
By Laura LorenzettiApril 8, 2015
PA: Mylan Headquarters
FinanceMylan goes big with $29 billion offer to buy Perrigo
By Laura LorenzettiApril 8, 2015
Pneumococcus Vaccine
EyebrowPfizer to stop selling vaccines in China after failing to get license renewal
By Reuters and Fortune EditorsApril 2, 2015
IL: Corporations In Illinois
FeaturesTakeda’s ready to shell out $2.2 billion to settle Actos drug cases
By Laura LorenzettiApril 1, 2015
FRANCE-HEALTH-ALLERGIES-POLLEN
RetailJ&J, Glaxo settle U.S. lawsuit over allergy ads
By ReutersMarch 30, 2015
First Day Of Trading For 2012 At The NYSE
FinanceDow gains 260 points as stock market jumps on news out of China
By Tom Huddleston Jr.March 30, 2015
Lincoln Continental To Be Phased Out
FeaturesGreece tries again and Ford brings back the Lincoln Continental — 5 things to know today
By Laura LorenzettiMarch 30, 2015
RetailWalgreens workers no longer want you to ‘Be Well’
By Ben GeierMarch 26, 2015
LeadershipWhere do CEOs with addictions go when they hit bottom?
By Daniel BukszpanMarch 25, 2015
Merck
FeaturesMerck halts study in light of melanoma drug’s success
By Laura LorenzettiMarch 24, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
FeaturesNovartis unit hit with $110 million gender discrimination suit
By ReutersMarch 17, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceValeant comes out a winner after upping its Salix bid to $11.1 billion
By Laura LorenzettiMarch 16, 2015
FRANCE-HEALTH-ALLERGIES-POLLEN
RetailSpring must be here! J&J sues Glaxo over allergy cure claims
By Geoffrey SmithMarch 13, 2015
1...
  • 93
  • 94
  • 95
  • 96
  • 97
...100
Most Popular
Middle East
Iran's attacks have collapsed, and the trend is 'overwhelmingly positive,' analysts say. But the military side is separate from politics and marketsAn image of a popular article
By Jason MaMarch 16, 2026
Investing
Peter Thiel is actively convincing billionaires to abandon The Giving Pledge — and it may be workingAn image of a popular article
By Jake AngeloMarch 16, 2026
Politics
'No, we didn’t': DOGE staffer admits Elon Musk’s cost-cutting agency failed to reduce the federal deficitAn image of a popular article
By Sasha RogelbergMarch 16, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.